Gene Transplant Market Report 2026

Gene Transplant Market Overview

• Gene Transplant market size has reached to $4.13 billion in 2025 • Expected to grow to $7.57 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Rise In Gene Therapy Fueling The Growth Of The Market Due To Advancements In Delivery Systems And Targeted Genetic Disorder Management • Market Trend: Advanced Automated Cloning Platforms Boost Gene Therapy Efficiency • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Gene Transplant Market?

Gene transplant refers to the process of introducing healthy or modified genes into a patient’s cells to replace or repair defective genes that cause disease. Its primary purpose is to correct genetic disorders, restore normal cell function, or provide therapeutic effects, such as enabling the immune system to target diseases. The main types of gene transplant are autologous and allogeneic. Autologous refers to a therapeutic approach where a patient’s own cells are collected, genetically modified, and then transplanted back into the same patient to treat or prevent a disease. It finds application in genetic disorders, cancer, rare diseases, and others, serving end users such as hospitals, research institutes, biotechnology companies, and others.

What Is The Gene Transplant Market Growth Forecast?

The gene transplant market size is expected to see rapid growth in the next few years. It will grow to $7.57 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing regulatory approvals for gene therapies, rising demand for personalized oncology treatments, expansion of allogeneic therapy pipelines, growing investment in gene therapy manufacturing, increasing collaboration between biotech firms and hospitals. Major trends in the forecast period include increasing adoption of autologous gene therapies, rising use of car-t cell treatments, growing development of off-the-shelf gene therapies, expansion of clinical gene transplant trials, enhanced focus on personalized genetic treatments.

What Is The Driver Of The Gene Transplant Market?

The rise in gene therapy is expected to propel the growth of the gene transplant market going forward. Gene therapy is a medical technique that involves modifying or manipulating a person's genes to treat or prevent disease. The rise in gene therapy is due to advancements in delivery systems, as they enable safe, efficient, and targeted transport of genetic material into cells. Gene therapy supports genetic disorder management by offering targeted treatments that correct or replace defective genes, making it a promising approach for previously untreatable conditions. It reduces disease symptoms and progression by addressing the root genetic cause, improving patient outcomes and quality of life. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the gene transplant industry.

Key Players In The Global Gene Transplant Market

Major companies operating in the gene transplant market are Bayer AG, Novartis AG, CSL Behring LLC, Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., CRISPR Therapeutics AG, Beam Therapeutics Inc., Rocket Pharmaceuticals Inc., Voyager Therapeutics Inc., Sangamo Therapeutics Inc., Editas Medicine Inc., Krystal Biotech Inc., bluebird bio Inc., Orchard Therapeutics plc, 4D Molecular Therapeutics Inc., Solid Biosciences Inc., uniQure N.V., MeiraGTx Holdings plc

Global Gene Transplant Market Trends and Insights

Major companies operating in the gene transplant market are focusing on developing advanced solutions, such as automated cloning platforms, to increase efficiency, improve precision, and accelerate the development of gene therapies. Automated cloning platforms are systems that automatically isolate and grow single cells into monoclonal lines, improving speed, accuracy, and consistency for gene transplant and therapy applications. For instance, in November 2024, iotaSciences Ltd., a UK-based life sciences technology company, launched the XT Single-Cell Cloning Platform, an automated cloning platform. It integrates automated microfluidics, AI-driven image analysis, and nano-dispensing technology to achieve high-throughput, precise isolation and cloning of individual cells. It is designed to accelerate gene therapy development by ensuring monoclonality, a critical regulatory requirement, while reducing processing time from weeks to days. This system also supports CRISPR-based gene editing applications by enabling efficient delivery of editing components to target cells, thereby enhancing the development of next-generation therapies.

What Are Latest Mergers And Acquisitions In The Gene Transplant Market?

In January 2025, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired Poseida Therapeutics Inc. for $1.5 billion. With this acquisition, Roche aims to strengthen its gene transplant and cell therapy portfolio, gaining access to Poseida’s proprietary non-viral gene editing and delivery technologies for treating genetic disorders and cancers. Poseida Therapeutics Inc. is a US-based pharmaceutical company developing gene transplant therapies.

What Defines the Gene Transplant Market?

The gene transplant market includes revenues earned by entities through gene therapy consultation, genetic engineering, cell processing and modification, vector delivery services, clinical trial support, and patient-specific treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Transplant Market Report 2026?

The gene transplant market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene transplant industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.